Biweekly docetaxel, fluorouracil, leucovorin, oxaliplatin (TEF) as first-line treatment for advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: safety and efficacy in a multicenter cohort.
about
Neoadjuvant therapy for gastroesophageal adenocarcinomaSignet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challengeFBXW7 expression is associated with prognosis and chemotherapeutic outcome in Chinese patients with gastric adenocarcinomaDocetaxel, oxaliplatin, and capecitabine combination chemotherapy for metastatic gastric cancer.An Unusual Course of Metastatic Gastroesophageal Cancer.Prognostic significance of frequent CLDN18-ARHGAP26/6 fusion in gastric signet-ring cell cancer.
P2860
Biweekly docetaxel, fluorouracil, leucovorin, oxaliplatin (TEF) as first-line treatment for advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: safety and efficacy in a multicenter cohort.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Biweekly docetaxel, fluorourac ...... icacy in a multicenter cohort.
@en
Biweekly docetaxel, fluorourac ...... icacy in a multicenter cohort.
@nl
type
label
Biweekly docetaxel, fluorourac ...... icacy in a multicenter cohort.
@en
Biweekly docetaxel, fluorourac ...... icacy in a multicenter cohort.
@nl
prefLabel
Biweekly docetaxel, fluorourac ...... icacy in a multicenter cohort.
@en
Biweekly docetaxel, fluorourac ...... icacy in a multicenter cohort.
@nl
P2093
P2860
P1433
P1476
Biweekly docetaxel, fluorourac ...... icacy in a multicenter cohort.
@en
P2093
Aziz Zaanan
Bruno Landi
Cécile Dalban
Céline Lepère
Emmanuel Mitry
Emmanuelle Samalin
Hajer Turki
Jean-François Seitz
Jean-Nicolas Vaillant
Laetitia Dahan
P2860
P2888
P304
P356
10.1007/S10120-013-0266-6
P50
P577
2013-06-06T00:00:00Z
P5875
P6179
1004072852